Financials
- Market Capitalization 801.73 M
- Employee 170
- Founded 2002
- CEO N/A
- Website www.dbv-technologies.com
- Headquarter France
- FIGI BBG0076D3T39
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-23.1
市销率
585.33
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 2596 | PHAR Pharming Group N.V. - ADS, each representing 10 | 11.70 USD | -1.27% | +0.69% | +16.42% | -14.66% | 820.97 M USD | ||
| 2604 | FDMT 4D Molecular Therapeutics, Inc. - Common Stock | 14.67 USD | -1.61% | -6.44% | +39.18% | +29.82% | 810.43 M USD | ||
| 2637 | NVCT Nuvectis Pharma, Inc. - Common Stock | 23.73 USD | -5.80% | +0.72% | +2.64% | +265.08% | 773.16 M USD | ||
| 2644 | AURA Aura Biosciences, Inc. - Common Stock | 7.40 USD | -3.90% | -5.13% | +5.56% | +18.40% | 767.42 M USD |